HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ryokuhei Manda Selected Research

Lymphatic Metastasis

1/2008Preoperative serum vascular endothelial growth factor-C (VEGF-C) levels predict recurrence in patients with esophageal cancer.
3/2006Clinicopathological characteristics and outcome indicators of stage II gastric cancer according to the Japanese classification of gastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ryokuhei Manda Research Topics

Disease

21Neoplasms (Cancer)
01/2008 - 09/2002
16Esophageal Neoplasms (Esophageal Cancer)
04/2009 - 09/2002
14Esophageal Squamous Cell Carcinoma
07/2007 - 09/2002
10Carcinoma (Carcinomatosis)
07/2007 - 07/2003
3Neoplasm Metastasis (Metastasis)
11/2005 - 11/2003
2Lymphatic Metastasis
01/2008 - 03/2006
1Deglutition Disorders (Dysphagia)
07/2007
1Pathologic Constriction (Stenosis)
07/2007
1Fistula
07/2007
1Hernia (Hernias)
04/2006
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
04/2006
1Stomach Ulcer (Gastric Ulcer)
04/2006
1Stomach Neoplasms (Stomach Cancer)
03/2006
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2005
1Hypoxia (Hypoxemia)
07/2004
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
05/2004
1Inflammation (Inflammations)
04/2004
1Chronic Disease (Chronic Diseases)
04/2004
1Psychotic Disorders (Schizoaffective Disorder)
06/2003

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
04/2009 - 09/2003
4Transforming Growth Factor beta (TGF-beta)IBA
07/2006 - 12/2002
3Biological ProductsIBA
07/2005 - 05/2004
2Indicators and Reagents (Reagents)IBA
03/2006 - 07/2004
2Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
07/2003 - 09/2002
1Messenger RNA (mRNA)IBA
04/2009
1Biomarkers (Surrogate Marker)IBA
01/2008
1Vascular Endothelial Growth Factor CIBA
01/2008
1Phenobarbital (Luminal)FDA Link
07/2007
1Inosine Triphosphate (ITP)IBA
04/2006
1methylene diphosphonateIBA
11/2005
1Technetium Tc 99m MedronateIBA
11/2005
1AntibodiesIBA
09/2005
1Secretory Leukocyte Peptidase InhibitorIBA
04/2005
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2005
1Insulin-Like Growth Factor Binding Protein 3IBA
09/2004
1Insulin-Like PeptidesIBA
09/2004
1LigandsIBA
09/2004
1Insulin-Like Growth Factor I (IGF-1)IBA
09/2004
1Cytotoxins (Cytolysins)IBA
07/2004
1Transcription Factors (Transcription Factor)IBA
07/2004
1Transforming Growth Factor beta1 (TGF beta 1)IBA
04/2004
1Interleukin-18 (Interleukin 18)IBA
03/2004
1Interleukin-12 (IL 12)IBA
03/2004
1InterleukinsIBA
03/2004
1Tumor Biomarkers (Tumor Markers)IBA
03/2004
1Co-Repressor ProteinsIBA
03/2004
1Cadherins (E-Cadherin)IBA
11/2003
1rhenium sulfide (ReS2)IBA
09/2003
1nedaplatinIBA
07/2003
1Fluorouracil (Carac)FDA LinkGeneric
07/2003
1MelatoninIBA
06/2003
1UbiquitinIBA
12/2002
1Ligases (Synthetase)IBA
12/2002
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
11/2002
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
11/2002
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2002
1Glucose Transporter Type 1IBA
09/2002

Therapy/Procedure

10Esophagectomy
11/2007 - 06/2003
5Lymph Node Excision (Lymph Node Dissection)
11/2007 - 11/2004
4Chemoradiotherapy
07/2007 - 07/2003
3Therapeutics
07/2007 - 09/2003
3Drug Therapy (Chemotherapy)
03/2006 - 07/2004
2Radiotherapy
07/2005 - 07/2003
2Neoadjuvant Therapy
11/2004 - 09/2002
1Self Expandable Metallic Stents
07/2007
1Stents
07/2007
1Fundoplication
04/2006
1Splenectomy
04/2006
1Gastrectomy
03/2006